NOT-DA-25-035: Notice of Early Expiration and Reissue of PAR-24-060, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"

Notice of Early Expiration and Reissue of PAR-24-060, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"

Notice Number:

NOT-DA-25-035

Key Dates

Release Date:

January 17, 2025

Related Announcements

January 8, 2024 - Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional). See NOFO PAR-24-060.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to alert applicants of the early termination of PAR-24-060, “Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)”. The Notice of Funding Opportunity (NOFO), PAR-24-060, will be terminated, effective immediately. No further applications will be accepted for consideration under this NOFO.

A new PAR to support “Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)" will be issued to correct review criteria. Applications for the new PAR will be due beginning on March 16, 2025.

Applicants are encouraged to consider applying to the new NOFO (expected to be published in February 2025): PAR-25-388 “Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)”.

Inquiries

Please direct all inquiries to:

Amy B Goldstein, PhD
National Institute on Drug Abuse
Telephone: 301-827-4124
Email: amy.goldstein@nih.gov